搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
Onlymyhealth
2 天
IBS-D: What Triggers Irritable Bowel Syndrome With Diarrhoea And How To Manage It?
Irritable bowel syndrome with diarrhoea IBS-D is a subtype of IBS that can be triggered by several factors Read to know what ...
2 天
Common Gastrointestinal Disorder Linked to Erectile Dysfunction
A recent study conducted on medical students by Peruvian researchers found that there may be a link between a chronic ...
3 天
Male infertility: Struggling in bedroom? This everyday health problem could be behind ...
Can fixing your gut fix your love life? Young men are twice as likely to have this hidden health problem that may cause ...
조선일보
5 天
Researchers develop inhalable nanoparticles for lung cancer treatment inspired by mussels
Researchers develop inhalable nanoparticles for lung cancer treatment inspired by mussels New technology transforms lung ...
Science Daily
5 天
Liver Disease News
Microbiome Changes in Chronic Liver Disease Highlight the Need for Personalized Treatment Nov. 18, 2024 — People with chronic liver disease have dramatic changes to the types and functions of ...
verywellhealth
6 天
The Best Probiotics for IBS
Probiotics may help relieve and improve IBS symptoms, like bloating, abdominal pain, and bowel movement irregularity, by ...
Medscape
6 天
IBS Relief: Is Combining Low-FODMAP and Gluten-Free Diets the Answer?
When weighing dietary interventions, clinicians should consider symptom improvements alongside diet complexity, cost, and ...
7 天
Dietician's five things you should try out to improve your gut health
A dietician has shared the five gut health trends we could see more of in the future - from faecal transplants to postbiotics ...
Pharmaceutical Technology
7 天
Rifaquizinone by TenNor Therapeutics for Irritable Bowel Syndrome: Likelihood of Approval
Rifaquizinone is under clinical development by TenNor Therapeutics and currently in Phase I for Irritable Bowel Syndrome.
Pharmaceutical Technology
7 天
CIN-103 by Cinphloro Pharma for Irritable Bowel Syndrome: Likelihood of Approval
CIN-103 is under clinical development by Cinphloro Pharma and currently in Phase II for Irritable Bowel Syndrome.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈